NCT06474533View on ClinicalTrials.gov

Fluoroethyltyrosine for the Evaluation of Intracranial Neoplasm

RecruitingOBSERVATIONAL
Enrollment

199

Participants

Timeline

Start Date

June 21, 2024

Primary Completion Date

August 31, 2028

Study Completion Date

August 31, 2028

Conditions
Intracranial Neoplasm
Interventions
DRUG

Fluorethyltyrosine (18-F)

Given intravenously (IV)

PROCEDURE

Positron Emission Tomography (PET)

Undergo Imaging Procedure

Trial Locations (1)

94143

RECRUITING

University of California, San Francisco, San Francisco

All Listed Sponsors
lead

Thomas Hope

OTHER